Home/Filings/4/0001230724-25-000007
4//SEC Filing

GUGGENHIME ANDREW 4

Accession 0001230724-25-000007

CIK 0001649094other

Filed

Sep 3, 8:00 PM ET

Accepted

Sep 4, 4:10 PM ET

Size

8.2 KB

Accession

0001230724-25-000007

Insider Transaction Report

Form 4
Period: 2025-09-02
GUGGENHIME ANDREW
PRESIDENT AND CFO
Transactions
  • Tax Payment

    Common Stock

    2025-09-02$31.56/sh1,270$40,081131,009 total
  • Tax Payment

    Common Stock

    2025-09-02$31.56/sh2,381$75,144128,628 total
  • Tax Payment

    Common Stock

    2025-09-02$31.56/sh1,429$45,099127,199 total
Footnotes (2)
  • [F1]Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs.
  • [F2]Includes 329 shares acquired under the Issuer's Employee Stock Purchase Plan on May 16, 2025.

Issuer

Vaxcyte, Inc.

CIK 0001649094

Entity typeother

Related Parties

1
  • filerCIK 0001230724

Filing Metadata

Form type
4
Filed
Sep 3, 8:00 PM ET
Accepted
Sep 4, 4:10 PM ET
Size
8.2 KB